Hydrocodone Bitartrate; Ibuprofen Patent Expiration

Hydrocodone Bitartrate; Ibuprofen was first introduced by Abbvie Inc in its drug Vicoprofen on Sep 23, 1997. 9 different companies have introduced drugs containing Hydrocodone Bitartrate; Ibuprofen.


Hydrocodone Bitartrate; Ibuprofen Patents

Given below is the list of patents protecting Hydrocodone Bitartrate; Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vicoprofen US6348216 Ibuprofen and narcotic analgesic compositions Jun 10, 2017

(Expired)

Abbvie
Vicoprofen US6599531 Method of making ibuprofen and narcotic analgesic compositions Jun 10, 2017

(Expired)

Abbvie



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Hydrocodone Bitartrate; Ibuprofen's patents.

Given below is the list recent legal activities going on the following patents of Hydrocodone Bitartrate; Ibuprofen.

Activity Date Patent Number
Patent litigations
File Marked Found 19 Feb, 2016 US6599531
Correspondence Address Change 05 Sep, 2007 US6599531
Recordation of Patent Grant Mailed 29 Jul, 2003 US6599531
Patent Issue Date Used in PTA Calculation 29 Jul, 2003 US6599531
Issue Notification Mailed 10 Jul, 2003 US6599531
Receipt into Pubs 23 Jun, 2003 US6599531
Application Is Considered Ready for Issue 18 Jun, 2003 US6599531
Receipt into Pubs 16 Jun, 2003 US6599531
Workflow - File Sent to Contractor 02 Apr, 2003 US6599531
Receipt into Pubs 28 Mar, 2003 US6599531


Hydrocodone Bitartrate; Ibuprofen's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydrocodone Bitartrate; Ibuprofen Generic API Manufacturers

Several generic applications have been filed for Hydrocodone Bitartrate; Ibuprofen. The first generic version for Hydrocodone Bitartrate; Ibuprofen was by Teva Pharmaceuticals Usa Inc and was approved on Apr 11, 2003. And the latest generic version is by Aurolife Pharma Llc and was approved on Jun 2, 2016.

Given below is the list of companies who have filed for Hydrocodone Bitartrate; Ibuprofen generic, along with the locations of their manufacturing plants worldwide.